Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Body Regions (1)
- Diagnosis (1)
- Education (1)
-
- Health Services Research (1)
- Higher Education (1)
- Medical Education (1)
- Medical Genetics (1)
- Nervous System (1)
- Nervous System Diseases (1)
- Nutritional and Metabolic Diseases (1)
- Public Health (1)
- Scholarship of Teaching and Learning (1)
- Teacher Education and Professional Development (1)
- Tissues (1)
Articles 1 - 2 of 2
Full-Text Articles in Neoplasms
Testing Extraction Of Dna From Lipid-Rich Tissues Using Various Reagents And Commercially Available Kits, Ryan V. Powers, Walker C. Kay, Jonathon C. Reynolds, Nathaniel E. Hill, Cole J. Farnsworth, Molly E. Henley, Alfred B. Amendolara, Noah D. Boekweg, John A. Kriak, Kyle B. Bills, David W. Sant
Testing Extraction Of Dna From Lipid-Rich Tissues Using Various Reagents And Commercially Available Kits, Ryan V. Powers, Walker C. Kay, Jonathon C. Reynolds, Nathaniel E. Hill, Cole J. Farnsworth, Molly E. Henley, Alfred B. Amendolara, Noah D. Boekweg, John A. Kriak, Kyle B. Bills, David W. Sant
Annual Research Symposium
No abstract provided.
Exploration Of Prostate Cancer Cells: The Significance Of Active Herv, Dakota Shepherd
Exploration Of Prostate Cancer Cells: The Significance Of Active Herv, Dakota Shepherd
Student Scholar Showcase
The second most common cancer in men is prostate cancer. Prostate cancer is traditionally diagnosed by a digital rectal exam. Blood tests can also be used to test for PSA (prostate-specific antigen). These two methods can be used together but can sometimes provide both false negative and false positive results. A new method of testing for prostate cancer could prove to be beneficial. Previous studies have shown that active HERV sequences have been identified in some cancers, including prostate cancer. We hypothesize that the presence of active HERV in prostate cancer lines is significant. In this study, rabbit polyclonal antibodies …